Poster campaign raises awareness of epilepsy on public transport
This week, for the first time ever, epilepsy is featuring as part of a high profile poster campaign across London's underground and bus networks.
Epilepsy Society welcomes new measures to ensure no babies are exposed to sodium valproate during pregnancy
New measures announced to stop babies being exposed to valproate in the womb
Valproate medicines are available in the UK under brand names such as Epilim, Epival, Episenta, Convulex and Orlept
No girl or woman should stop taking valproate without first consulting her doctor.
Epilepsy Society praises Government decision to review handling of concerns around sodium valproate
Epilepsy Society's chief executive Clare Pelham has praised the Government's decision to announce a forward-looking review that will address the way the healthcare system has handled the concerns of patients in its care and make certain that lessons are learned and history does not repeat itself.
EMA publishes recommendations on sodium valproate
New measures to avoid the exposure of unborn babies to the epilepsy drug sodium valproate have been announced by the safety committee of the European Medicines Agency (EMA).
Clare Pelham joins expert group on sodium valproate
Epilepsy Society's chief executive Clare Pelham has joined the Sodium Valproate Expert Working Group which supports the Government's Commission on Human Medicines.
MPs debate safety issues around sodium valproate in House of Commons
Although we could not see them as we watched today's sodium valproate debate via Parliament Live TV, the presence of three women -Janet Williams, Emma Murphy and Deborah Mann - as they sat in the public gallery, was very much felt in the House of Commons.